OBJECTIVE: To develop and evaluate computer algorithms with high negative predictive values that augment traditional surveillance for central line-associated bloodstream infection (CLABSI). SETTING: Barnes-Jewish Hospital, a 1,250-bed tertiary care academic hospital in Saint Louis, Missouri. METHODS: We evaluated all adult patients in intensive care units who had blood samples collected during the period from July 1, 2005, to June 30, 2006, that were positive for a recognized pathogen on culture. Each isolate recovered from culture was evaluated using the definitions for nosocomial CLABSI provided by the National Healthcare Safety Network of the Centers for Disease Control and Prevention. Using manual surveillance by infection prevention specialists as the gold standard, we assessed the ability of various combinations of dichotomous rules to determine whether an isolate was associated with a CLABSI. Sensitivity, specificity, and predictive values were calculated. RESULTS: Infection prevention specialists identified 67 cases of CLABSI associated with 771 isolates recovered from blood samples. The algorithms excluded approximately 40%-62% of the isolates from consideration as possible causes of CLABSI. The simplest algorithm, with 2 dichotomous rules (ie, the collection of blood samples more than 48 hours after admission and the presence of a central venous catheter within 48 hours before collection of blood samples), had the highest negative predictive value (99.4%) and the lowest specificity (44.2%) for CLABSI. Augmentation of this algorithm with rules for common skin contaminants confirmed by another positive blood culture result yielded in a negative predictive value of 99.2% and a specificity of 68.0%. CONCLUSIONS: An automated approach to surveillance for CLABSI that is characterized by a high negative predictive value can accurately identify and exclude positive culture results not representing CLABSI from further manual surveillance.
OBJECTIVE: To develop and evaluate computer algorithms with high negative predictive values that augment traditional surveillance for central line-associated bloodstream infection (CLABSI). SETTING: Barnes-Jewish Hospital, a 1,250-bed tertiary care academic hospital in Saint Louis, Missouri. METHODS: We evaluated all adult patients in intensive care units who had blood samples collected during the period from July 1, 2005, to June 30, 2006, that were positive for a recognized pathogen on culture. Each isolate recovered from culture was evaluated using the definitions for nosocomial CLABSI provided by the National Healthcare Safety Network of the Centers for Disease Control and Prevention. Using manual surveillance by infection prevention specialists as the gold standard, we assessed the ability of various combinations of dichotomous rules to determine whether an isolate was associated with a CLABSI. Sensitivity, specificity, and predictive values were calculated. RESULTS:Infection prevention specialists identified 67 cases of CLABSI associated with 771 isolates recovered from blood samples. The algorithms excluded approximately 40%-62% of the isolates from consideration as possible causes of CLABSI. The simplest algorithm, with 2 dichotomous rules (ie, the collection of blood samples more than 48 hours after admission and the presence of a central venous catheter within 48 hours before collection of blood samples), had the highest negative predictive value (99.4%) and the lowest specificity (44.2%) for CLABSI. Augmentation of this algorithm with rules for common skin contaminants confirmed by another positive blood culture result yielded in a negative predictive value of 99.2% and a specificity of 68.0%. CONCLUSIONS: An automated approach to surveillance for CLABSI that is characterized by a high negative predictive value can accurately identify and exclude positive culture results not representing CLABSI from further manual surveillance.
Authors: Jonathan R Edwards; Kelly D Peterson; Mary L Andrus; James S Tolson; Joy S Goulding; Margaret A Dudeck; Randy B Mincey; Daniel A Pollock; Teresa C Horan Journal: Am J Infect Control Date: 2007-06 Impact factor: 2.918
Authors: David K Warren; Wasim W Quadir; Christopher S Hollenbeak; Alexis M Elward; Michael J Cox; Victoria J Fraser Journal: Crit Care Med Date: 2006-08 Impact factor: 7.598
Authors: L Pokorny; A Rovira; M Martín-Baranera; C Gimeno; C Alonso-Tarrés; J Vilarasau Journal: Infect Control Hosp Epidemiol Date: 2006-04-20 Impact factor: 3.254
Authors: Stijn I Blot; Pieter Depuydt; Lieven Annemans; Dominique Benoit; Eric Hoste; Jan J De Waele; Johan Decruyenaere; Dirk Vogelaers; Francis Colardyn; Koenraad H Vandewoude Journal: Clin Infect Dis Date: 2005-10-25 Impact factor: 9.079
Authors: Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein Journal: MMWR Recomm Rep Date: 2002-08-09
Authors: William E Trick; Brandon M Zagorski; Jerome I Tokars; Michael O Vernon; Sharon F Welbel; Mary F Wisniewski; Chesley Richards; Robert A Weinstein Journal: Emerg Infect Dis Date: 2004-09 Impact factor: 6.883
Authors: Michael E Matheny; Fern Fitzhenry; Theodore Speroff; Jacob Hathaway; Harvey J Murff; Steven H Brown; Elliot M Fielstein; Robert S Dittus; Peter L Elkin Journal: AMIA Annu Symp Proc Date: 2009-11-14
Authors: Heather E Hsu; Erica S Shenoy; Douglas Kelbaugh; Winston Ware; Hang Lee; Pearl Zakroysky; David C Hooper; Rochelle P Walensky Journal: Am J Infect Control Date: 2015-03-31 Impact factor: 2.918
Authors: Sara C Keller; Darren R Linkin; Neil O Fishman; Ebbing Lautenbach Journal: Infect Control Hosp Epidemiol Date: 2013-05-21 Impact factor: 3.254
Authors: Maaike S M van Mourik; Rolf H H Groenwold; Jan Willem Berkelbach van der Sprenkel; Wouter W van Solinge; Annet Troelstra; Marc J M Bonten Journal: PLoS One Date: 2011-08-02 Impact factor: 3.240
Authors: Anna Maria Kaiser; Evelien de Jong; Sabine Fm Evelein-Brugman; Jan M Peppink; Christina Mje Vandenbroucke-Grauls; Armand Rj Girbes Journal: Ann Intensive Care Date: 2014-12-21 Impact factor: 6.925
Authors: Carlos Mejia-Chew; Jane A O'Halloran; Margaret A Olsen; Dustin Stwalley; Ryan Kronen; Charlotte Lin; Ana S Salazar; Lindsey Larson; Kevin Hsueh; William G Powderly; Andrej Spec Journal: Lancet Infect Dis Date: 2019-09-24 Impact factor: 25.071
Authors: Soraya Cherifi; Georges Mascart; Anne Dediste; Marie Hallin; Michèle Gerard; Marie-Laurence Lambert; Baudouin Byl Journal: Antimicrob Resist Infect Control Date: 2013-04-03 Impact factor: 4.887